Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Urokinase-type plasminogen activator prostate cancer

Miyake H, Hara I, Yamanaka K, Gohji K, Arakawa S, Kamidono S. Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer. Prostate 1999 39(2) 123-129. [Pg.101]

Nl. Nichimura, K., Matsumiya, K., Miura, H., et al.. Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU 145 prostate cancer cells. Int. J. Androl. 26, 175-179 (2003). [Pg.130]

Usher PA, Thomsen OF, Iversen P, Johnsen M, Brunner N, Hoyer-Hansen G, et al. Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissue. Int J Cancer 2005 113(6) 870—880. [Pg.101]

See other pages where Urokinase-type plasminogen activator prostate cancer is mentioned: [Pg.40]    [Pg.139]   
See also in sourсe #XX -- [ Pg.87 ]



SEARCH



Active type

Cancer types

Cancer, prostat

Plasminogen

Plasminogen activation

Plasminogen activators

Prostate cancer

Prostatic cancer

Urokinase-type plasminogen activator

© 2024 chempedia.info